Abstract
Objective: We evaluated the prognostic factors for thymoma that remain controversial.Methods: We studied 72 consecutive patients treated for thymoma during the period between 1966 and 1997. Recurrence-free interval rates and overall survival rates calculated by the Kaplan-Meier method were compared using logrank test by the Masaoka stage, extent of surgical resection, histology, or associated disease(s). Multivariate analysis was performed using Cox's proportional hazards model.Results: Thirty-two thymomas were at Masaoka stage I, 9 at stage II, 15 at stage III, and 16 were at stage IV. There were 56 complete resections, 7 incomplete resections (2 at stage III and 5 at stage IV), and 9 biopsies (1 at stage III and 8 at stage IV). Forty-one thymomas were cortical, 16 medullary, and 15 were mixed form. Association of myasthenia gravis was found in 20 patients, and pure red cell aplasia in 7. After an average follow-up period of 103 months, the recurrence-free 5-, 10-, 15-year interval rate was 89%, 80%, 80%, respectively, and overall 5-, 10-, 15-year survival rate was 86%, 71%, 59%, respectively. Factors influencing the recurrence-free interval and overall survival included the Masaoka stage, extent of surgical resection, and association with pure red cell aplasia. Multivariate analysis revealed stage IV tumor and association with pure red cell aplasia as risk factors for recurrence. Pure red cell aplasia indicated poor prognosis for overall survival.Conclusions: Masaoka stage, extent of surgical resection, and association with pure red cell aplasia were prognostic factors for thymoma. Multidisciplinary treatment for stage IV tumors and better control of pure red cell aplasia, if associated, should be investigated.
Similar content being viewed by others
References
Marino M, Muller-Hermelink HK. Thymoma and thymic carcinoma: relation of thymoma epithelial cells to the cortical and medullary differentiation of the thymus. Virchow Arch [A] 1985; 407: 119–49.
Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1982; 48: 2485–92.
Verley JM, Hollman KH. Thymoma: a comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 1985; 55: 1074–86.
Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF. Thymoma: a clinicopathologic review. Cancer 1987; 60: 2727–43.
Pescarmona E, Rendina EA, Venuta F, Arcangelo ED, Pagani M, Ricci C, et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 1990; 50: 534–8.
Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991; 51: 152–6.
Gamondes JP, Balawi A, Greenland T, Adleine P, Mornex JF, Maret G. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardio-thorac Surg 1991; 5: 124–31.
Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995; 60: 908–14.
Venuta F, Rendina EA, Pescarmona EO, De Giacomo T, Vegna ML, Fazi P, et al. Multimodality treatment of thymoma: a prospective study. Ann Thorac Surg 1997; 64: 1585–92.
Gripp S, Hilgers K, Wurm R, Schmitt G. Thymoma: prognostic factors and treatment outcomes. Cancer 1998; 83: 1495–503.
Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y, et al. Recurrence of thymoma: clinicopathological features, therapy and prognosis. Ann Thorac Surg 1985; 39: 165–9.
Nakahara K, Ohno K, Hashimoto J, Maeda H, Miyoshi S, Sakurai M, et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 1988; 95: 1041–7.
Regnard JF, Magdeleinat P, Dromer C, Dulmet E, De Montpreville V, Levi JF, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996; 112: 376–84.
Haniuda M, Miyazawa M, Yoshida K, Oguchi M, Sakai F, Izuno I, et al. Is postoperative radiotherapy for thymoma effective? Ann Surg 1996; 224: 219–24.
Martinez LQ, Wilkins W, Choi N, Efird J, Hug E, Harris NL. Thymoma: histologic subclassification is an independent prognostic factor. Cancer 1994; 74: 606–17.
Fornasiero A, Daniele O, Ghiotto C, Piazza M, Fiore-Donati L, Calabro F, et al. Chemotherapy for invasive thymoma: a13-year experience. Cancer 1991; 68: 30–3.
Shin DM, Walsh GL, Komaki R, Putnam JB, Nesbitt J, Ro JY, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 1998; 129: 100–4.
Macchiarini P, Chella A, Ducci F, Rossi B, Testi C, Bevilacqua G, et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 1991; 68: 706–13.
Sonobe M, Nakagawa M, Ikegami N, Suzumura Y, Nagasawa M, Shindo T. Two cases of intraoperative intrathoracic hypotonic chemotherapy for stage IVa thymoma with pleural effusion (Eng abstr). J Jpn Assn Chest Surg 1998; 12: 623–8.
Kirschner PA. Reoperation for thymoma: report of 23 cases. Ann Thorac Surg 1990; 49: 550–5.
Regnard JF, Zinzindohoue F, Magdeleinat P, Guibert L, Spaggiari L, Levasseur P. Results of re-resection for recurrent thymomas. Ann Thorac Surg 1997; 64: 1593–8.
Bernatz PE, Harrison EG, Clagett OT. Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg 1961; 42: 424–44.
Wilkins KB, Sheikh E, Green R, Patel M, George S, Takano M, et al. Clinical and pathological predictors of survival in patients with thymoma. Ann Surg 1999; 230: 562–74.
Masaoka A, Hashimoto T, Shibata K, Yamanaka Y, Nakamae K, Iizuka M. Thymomas associated with pure red cell aplasia: histologic and follow-up studies. Cancer 1989; 64: 1872–8.
Clark DA, Dessypris EN, Krantz SB. Studies on pure red cell aplasia: XI. result of immunosuppressive treatment of 37 patients. Blood 1984; 63: 277–86.
Erslev AJ, Soltan A. Pure red cell aplasia: a review. Blood Reviews 1996; 10: 20–8.
Mamiya S, Itoh T, Miura AB. Acquired pure red cell aplasia in Japan. Eur J Haematol 1997; 59: 199–205.
Mukaida T, Aoe M, Yamashita M, Date H, Ando A, Shimizu N. Four cases of thymoma associated with pure red cell aplasia (Eng abstr). J Jpn Assn Thorac Surg 1997; 45: 96–101.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sonobe, M., Nakagawa, M., Ichinose, M. et al. Thymoma. Jpn J Thorac Cardiovasc Surg 49, 35–41 (2001). https://doi.org/10.1007/BF02913121
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02913121